Your browser doesn't support javascript.
loading
Gene expression profile and injury sites in mice treated with Shiga toxin 2 and lipopolysaccharide as a Shiga toxin-associated hemolytic uremic syndrome model.
Kume, Yohei; Go, Hayato; Maeda, Ryo; Suyama, Kazuhide; Mori, Tsutomu; Kawasaki, Yukihiko; Hashimoto, Koichi; Hosoya, Mitsuaki.
Afiliación
  • Kume Y; Department of Pediatrics, Fukushima Medical University School of Medicine, Fukushima, Japan.
  • Go H; Department of Pediatrics, Fukushima Medical University School of Medicine, Fukushima, Japan.
  • Maeda R; Department of Pediatrics, Fukushima Medical University School of Medicine, Fukushima, Japan.
  • Suyama K; Department of Pediatrics, Fukushima Medical University School of Medicine, Fukushima, Japan.
  • Mori T; Department of Human Life Sciences, School of Nursing, Fukushima Medical University School of Medicine, Fukushima, Japan.
  • Kawasaki Y; Department of Pediatrics, Fukushima Medical University School of Medicine, Fukushima, Japan.
  • Hashimoto K; Department of Pediatrics, Fukushima Medical University School of Medicine, Fukushima, Japan.
  • Hosoya M; Department of Pediatrics, Fukushima Medical University School of Medicine, Fukushima, Japan.
Physiol Genomics ; 54(5): 153-165, 2022 05 01.
Article en En | MEDLINE | ID: mdl-35384732

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Toxina Shiga II / Síndrome Hemolítico-Urémico Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Animals Idioma: En Año: 2022 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Toxina Shiga II / Síndrome Hemolítico-Urémico Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Animals Idioma: En Año: 2022 Tipo del documento: Article